RxSight, Inc.
RXST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $530 | $1,023 | $1,387 |
| - Cash | $30 | $40 | $28 | $17 |
| + Debt | $10 | $12 | $12 | $12 |
| Enterprise Value | – | $501 | $1,007 | $1,383 |
| Revenue | $30 | $34 | $38 | $40 |
| % Growth | -9.8% | -11.2% | -5.8% | – |
| Gross Profit | $24 | $25 | $28 | $29 |
| % Margin | 79.9% | 74.9% | 74.8% | 71.6% |
| EBITDA | -$9 | -$11 | -$7 | -$5 |
| % Margin | -29.5% | -32.6% | -19.5% | -13.4% |
| Net Income | -$10 | -$12 | -$8 | -$6 |
| % Margin | -32.4% | -35% | -21.6% | -14.8% |
| EPS Diluted | -0.24 | -0.29 | -0.2 | -0.15 |
| % Growth | 17.2% | -45% | -33.3% | – |
| Operating Cash Flow | -$1 | -$4 | -$9 | -$4 |
| Capital Expenditures | -$1 | -$2 | -$1 | -$1 |
| Free Cash Flow | -$2 | -$6 | -$9 | -$5 |